Lack of IL-10 synthesis by murine alveolar macrophages upon lipopolysaccharide exposure. Comparison with peritoneal macrophages

Journal of Leukocyte Biology

Volumn 67, Issue 4, 2000, Pages 545-552

  Salez, L ^a   Singer, M ^a   Balloy, V ^a   Creminon, C ^a   Chignard, M ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

cAMP; Inflammation; Lung

Indexed keywords

INTERLEUKIN 10; LIPOPOLYSACCHARIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 0033849667     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.67.4.545     Document Type: Article

References (51)

1. The role of the host defence response in the progression and outcome of ARDS: Pathophysiological correlations and response to glucocorticoid treatment
2. Biological markers of acute lung injury: Prognostic and pathogenetic significance
3. Endotoxin and lung injury
4. Tumor necrosis, cachexia, shock, and inflammation: A common mediator
5. Tumor necrosis factor: An updated review of its biology
6. Role of tumor necrosis factor-alpha in disease states and inflammation
7. Tumor necrosis factor-alpha blockade prevents neutrophil CD18 receptor upregulation and attenuates acute lung injury in porcine sepsis without inhibition of neutrophil oxygen radical generation
8. A mouse model of lung injury induced by microbial products: Implication of tumor necrosis factor
9. Effect of cyclo-oxygenase inhibitors and modulators of cyclic AMP formation on lipopolysaccharide-induced neutrophil infiltration in mouse lung
10. Dynamics of dibutyryl cyclic AMP- and prostaglandin E2-mediated suppression of lipopolysaccharide-induced tumor necrosis factor alpha gene expression
11. Lipopolysaccharide-induced gene expression in murine peritoneal macrophages is selectively suppressed by agents that elevate intracellular cAMP
12. Phosphodiesterase (PDE) 4 inhibitors: Anti-inflammatory drugs of the future?
13. Evidence for the involvement of interleukin-10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2
14. Up-regulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs
15. Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-α and IL-6 release by endotoxin-stimulated macrophages
16. Interleukin-10
17. Interleukin-10: Biology, role in inflammation and autoimmunity
18. IL-10 inhibits cytokine production by activated macrophages
19. Macrophage deactivation by interleukin-10
20. Interleukin-10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia
21. Human tumor necrosis factor receptor (p55) and interleukin-10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses
22. Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: Effect of timing of recombinant human IL-10 administration
23. Effects of rolipram on cyclic AMP levels in alveolar macrophages and lipopolysaccharide-induced inflammation in mouse lung
24. Immunometric assay of low molecular weight haptens containing primary amino groups
25. Enzyme immunometric assay of thyroliberin (TRH)
26. Production of monoclonal antibodies against interleukin-1 alpha and -1 beta. Development of two enzyme immunometric assays (EIA) using acetylcholinesterase and their application to biological media
27. Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: An alternative to radioimmunoassay
28. Strategies of anti-cytokine monoclonal antibody development: Immunoassay of IL-10 and IL-5 in clinical samples
29. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
30. LPS-binding proteins and receptors
31. Differential regulation of monocytic tumor necrosis factor-alpha and interleukin-10 expression
32. Calcium entry blockers increase interleukin-10 production in endotoxemia
33. Relative production of tumour necrosis factor-alpha and interleukin-10 in adult respiratory distress syndrome
34. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis
35. Regulation of intedeukin-10 release by tumor necrosis factor in humans and chimpanzees
36. Amrinone and theophylline differentially regulate cytokine and nitric oxide production in endotoxemic mice
37. Enhanced production of LPS-induced cytokines during differentiation of human monocytes to macrophages. Role of LPS receptors
38. Decreased production of TGF-beta 1 by human alveolar macrophages compared with blood monocytes
39. Human macrophages induced in vitro by macrophage colony-stimulating factor are deficient in IL-12 production
40. Development, differentiation, and phenotypic heterogeneity of murine tissue macrophages
41. Origin, kinetics, and characteristics of pulmonary macrophages in the normal steady state
42. Transcription factors that regulate monocyte/macrophage differentiation
43. Immunomodulatory functions of surfactant
44. Surfactant protein A regulates cytokine production in the monocytic cell line THP-1
45. Surfactant protein A protects growing cells and reduces TNF-α activity from LPS-stimulated macrophages
46. Expression of tumor necrosis factor-alpha gene in alveolar macrophages from patients with the adult respiratory distress syndrome
47. Inhibition of macrophage inflammatory protein-1α expression by IL-10
48. Regulation of human alveolar macrophage inflammatory cytokine production by interleukin-10
49. Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1α, granulocytemacrophage colony-stimulating factor, and interferon-γ release from alveolar macrophages in asthma
50. Alveolar macrophage interleukin (IL)-10 and IL-12 production in atopic asthma
51. Cytokines in adult respiratory distress syndrome